CSL Sees 2027 NPAT Growth of 5% at Constant Currency
CSL Ltd. forecast no revenue growth and underlying net profit after tax growth of about 5% at constant currency for fiscal 2027, signaling another subdued year as Australia’s largest health-care...
By Amber Tong and Karen Leigh · Bloomberg
CSL Ltd. forecast no revenue growth and underlying net profit after tax growth of about 5% at constant currency for fiscal 2027, signaling another subdued year as Australia’s largest health-care company pushes ahead with a sweeping restructuring.